Delivery Order SPE2DB22D3501-SPE2DB25FUV08
- Not listed
- This is a federal contract award to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 100 units of Methylphenidate ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,301.60 and an ultimate completion date of June 6, 2025. The contract is not...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,493.83, is for the delivery of Methylphenidate ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2023. Amerisourcebergen holds a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 54 mg tablets, a prescription medication, with a ceiling value of $1,345.12 and a completion date of January 13, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $1,760.40 and a period of performance through February 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,555.72 delivery order is for the supply of Methylphenidate ER 54 mg tablets, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract is a firm fixed-price Delivery Order, with a completion date of May 29, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 27 mg tablets, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,517.80 and a period of performance through June 27, 2025. The contract is not set aside and was awarded on June 26, 2025. Amerisourcebergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 18 mg tablets, a prescription medication used to treat attention-deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $1,719.36 and a performance period ending on July 14, 2025. This award is not set-aside and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,039,815 units of Methylphenidate ER 36 mg tablets, a medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $8,384.84 and an ultimate completion date of January 27, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.12 Firm Fixed Price delivery order contract is for the supply of Methylphenidate ER 18 mg tablets, a medication used to treat ADHD. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 54mg Methylphenidate ER tablets, a medication commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $2,281.61 and a period of performance ending on February 5, 2025. This award is...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FUV08Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 54 mg tablets, a medication used to treat conditions such as ADHD. The contract has a ceiling value of $1,727.32 and is a Firm Fixed Price Delivery Order with a period of performance through March 7, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/6/25 |